BioCentury
ARTICLE | Company News

Why Brii Bio partnered with microbiome start-up Artizan

June 11, 2019 1:04 AM UTC

In its latest move to bring innovation to infectious diseases in China, Brii Bio has partnered with microbiome start-up Artizan, which is approaching IBD as if it were an infectious disease.

Artizan Biosciences Inc. (New Haven, Conn.) emerged from stealth on Monday with a $12 million series A round to bring its lead program, targeting inflammatory bowel disease, to IND-enabling studies and use its IgA-SEQ platform to identify new IBD targets...